ROKIO

Agouron Pharmaceuticals, Inc.

Application Filed: 2003-04-02

Trademark Application Details

Status

605

Dead/Abandoned

ABANDONED – EXPRESS AFTER PUB

Research	OneLook Acronym Finder
Serial Number	78233098
Mark Drawing Code	1000: Typeset: Word(s)/letter(s)/number(s)
Attorney Name	Jane Ungaro
Law Office Assigned	L80
Employee Name	SHARPER JR, SAMUEL E

Timeline

2003-04-02	Application Filed
2003-11-04	Published for Opposition
2004-12-21	Location: INTENT TO USE SECTION
2007-06-06	Abandon
2007-06-06	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Agouron Pharmaceuticals, Inc.
Address	10777 Science Center Drive San Diego CA 92121
Legal Entity Type	Corporation
Legal Entity State	CA

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Jane Ungaro
Pfizer Inc.
Pfizer Inc., Legal Division - Trademarks
150 East 42nd Street
New York NY 10017

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDs

Type Code

Type

GS0051

Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDs

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	2003-08-28	1 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2003-09-09	2 CNSA P:
NOTICE OF PUBLICATION	2003-10-15	3 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2003-11-04	4 PUBO A:Allowance for Publication
EXTENSION OF TIME TO OPPOSE RECEIVED	2003-12-02	5 ETOF T:TTAB Proceeding
PAPER RECEIVED	2004-04-08	6 MAIL I:Incoming Correspondence
NOA MAILED - SOU REQUIRED FROM APPLICANT	2004-06-15	7 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2004-12-14	8 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2004-12-14	9 EXT1 S:
EXTENSION 1 GRANTED	2004-12-22	10 EX1G S:
ASSIGNED TO EXAMINER	2005-03-07	11 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER	2005-03-08	12 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER	2005-03-21	13 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER	2005-05-31	14 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER	2005-06-01	15 DOCK D:Assigned to Examiner
TEAS EXTENSION RECEIVED	2005-06-10	16 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2005-06-10	17 EXT2 S:
EXTENSION 2 GRANTED	2005-06-10	18 EX2G S:
TEAS EXTENSION RECEIVED	2005-11-18	19 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2005-11-18	20 EXT3 S:
EXTENSION 3 GRANTED	2005-11-18	21 EX3G S:
TEAS EXTENSION RECEIVED	2006-06-14	22 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2006-06-14	23 EXT4 S:
EXTENSION 4 GRANTED	2006-06-14	24 EX4G S:
TEAS EXTENSION RECEIVED	2006-12-14	25 EEXT I:Incoming Correspondence
EXTENSION 5 FILED	2006-12-14	26 EXT5 S:
EXTENSION 5 GRANTED	2006-12-14	27 EX5G S:
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2007-01-08	28 TCCA I:Incoming Correspondence
TEAS EXPRESS ABANDONMENT RECEIVED	2007-06-06	29 EXAR I:Incoming Correspondence
ABANDONMENT - AFTER PUBLICATION	2007-06-06	30 ABN5 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - AFTER PUBLICATION	2007-06-06	31 MAB5 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ROKIO 78240375 not registered Dead/Abandoned	Rokio, Inc. 2003-04-22
ROKIO 78233098 not registered Dead/Abandoned	Agouron Pharmaceuticals, Inc. 2003-04-02
ROKIO 77860433 not registered Dead/Abandoned	Agouron Pharmaceuticals, Inc. 2009-10-29
ROKIO 77069083 not registered Dead/Abandoned	Agouron Pharmaceuticals, Inc. 2006-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.